Concept:
The evaluation of a patient with newly diagnosed or poorly controlled hypertension involves assessing for Target Organ Damage (TOD) to guide risk stratification and therapeutic intensity.
The major target organs damaged by chronic hypertension include the heart (left ventricular hypertrophy, heart failure), the brain (stroke, TIA), the eyes (retinopathy), and the kidneys (chronic kidney disease).
The patient already has evidence of end-organ damage in the eyes (grade II hypertensive retinopathy).
Explanation:
• Assessing renal end-organ damage is mandatory in all hypertensive patients.
• Hypertension causes nephrosclerosis, which manifests early as endothelial dysfunction and increased glomerular permeability.
• The earliest, most sensitive, and most widely accessible non-invasive marker for hypertensive renal target organ damage is the presence of microalbuminuria or overt proteinuria.
• A simple urine protein estimation (specifically, an spot urine albumin-to-creatinine ratio) is therefore critical in risk-stratifying the patient. The presence of proteinuria heavily influences the choice of antihypertensive agents (e.g., mandating the use of ACE inhibitors or ARBs) and indicates a higher cardiovascular risk profile.
• Option (B) (Serum cortisol) and Option (D) (24-hour urinary catecholamines) are specific tests used to screen for secondary causes of hypertension (Cushing's syndrome and Pheochromocytoma, respectively), not to screen for end-organ damage.
• Option (C) (Renal Doppler ultrasound) is used to screen for renal artery stenosis, another secondary cause of hypertension. While useful in specific clinical contexts (like resistant hypertension or abdominal bruits), it is not a routine test to evaluate generalized target organ damage.
Final answer:
Urine protein estimation is the most appropriate investigation to detect renal target organ damage and guide antihypertensive therapy.